Characterisation of factor VIII receptors.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D001212:Asialoglycoproteins; D001792:Blood Platelets / Q000502:physiology*; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology; D006023:Glycoproteins / Q000097:blood; D006801:Humans; D007158:Immunologic Techniques; D046911:Macromolecular Substances; D008565:Membrane Proteins / Q000097:blood; D008970:Molecular Weight; D010974:Platelet Aggregation / Q000187:drug effects; D019038:Platelet Glycoprotein GPIb-IX Complex; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface / Q000502:physiology*; D012310:Ristocetin / Q000494:pharmacology; D013931:Thromboxanes / Q000097:blood; D014841:von Willebrand Factor / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*
D001212:Asialoglycoproteins; D006023:Glycoproteins; D046911:Macromolecular Substances; D008565:Membrane Proteins; D019038:Platelet Glycoprotein GPIb-IX Complex; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface; D013931:Thromboxanes; C044131:asialo-von Willebrand Factor; C023592:glycocalicin; D014841:von Willebrand Factor; C028254:von Willebrand factor receptor; D012310:Ristocetin; D000244:Adenosine Diphosphate; D004837:Epinephrine